key: cord-1037520-lwbjrk33
authors: Ayas, Najib T.; Fraser, Kristin L.; Giannouli, Eleni; Hanly, Patrick J.; Kendzerska, Tetyana; Katz, Sherri Lynne; Lachmann, Brandy N.; Lajoie, Annie; Minville, Caroline; Morrison, Debra; Narang, Indra; Povitz, Marcus; Skomro, Robert; Spurr, Kathy F.
title: KEY HIGHLIGHTS from the Canadian Thoracic Society’s Position Statement on Optimizing the Management of Sleep Disordered Breathing during the COVID-19 Pandemic.
date: 2020-06-06
journal: Chest
DOI: 10.1016/j.chest.2020.05.572
sha: 016ed9155ea55e9177ad71450721855e84ff9f53
doc_id: 1037520
cord_uid: lwbjrk33

nan

No, unless a clinician determines that a case is "extremely urgent". For example: unstable cardiopulmonary disease in which SDB is a substantial contributor (e.g. right heart failure, nocturnal angina, hypercapnia in the setting of neuromuscular disease, and/or severe nocturnal hypoxemia).

If testing is required, it should be done in-home with disposable equipment if possible. Otherwise, patients should be screened for COVID before sleep laboratory testing, and attend alone, if possible (e.g. may not be possible if the patient is a minor). Staff must have proper PPE, and the equipment and space must be cleaned. PAP (positive airway pressure) titration studies should be avoided, as PAP is thought to generate aerosols.

In selected patients, an empiric treatment of auto-titrating PAP, nocturnal oxygen, bilevel positive airway pressure, etc. could be tried until diagnostic testing can be done. Suitable patients for this include: unstable/severe cardiopulmonary disease, neuromuscular disease and respiratory distress/hypercapnia, severe nocturnal hypoxemia, substantial excessive daytime sleepiness with severe impairment of quality of life/daytime function. However, this should be done with specialist consultation (respiratory, sleep).

No, these are to be avoided in favour of telemedicine/telephone visits/consultations. Caregivers should take appropriate precautions when applying PAP for others.

The need should be weighed against the risks of viral transmission. If PAP is continued, the patient should use their own equipment/mask, if possible, and the hospital should follow its infection control protocols.

The risks and benefits of immediate therapy need to be weighed carefully. However, if therapy could be life-saving, then it should be started according to the hospital's infection control protocols.

These recommendations are subject to change as information regarding COVID-19 and its effects are further understood. We plan to update this guidance as new epidemiologic and other information become available (https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirusinfection/health-professionals.html). This information will help to guide future de-escalation of precautions with respect to sleep disordered breathing related services. We recommend monitoring the Canadian Thoracic Society website (https://cts-sct.ca/covid-19/) for updates.

Helping Canadian health care providers to optimize sleep disordered breathing management for their patients during the COVID-19 pandemic